ArticleBiomaterials research2025

Hsa_piR_016975 Is a Novel Target of Nanotherapy that Boosts Hepatoma Progression and Sorafenib Resistance by Abating Maspin/GPX4-Mediated Ferroptosis.

Wei Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.